Drug Approval | April 28, 2024
Zydus receives final approval from USFDA for Tretinoin Cream
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in Chronic Kidney Disease (CKD) patients
Zydus is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
Subscribe To Our Newsletter & Stay Updated
